Silo Pharma (SILO) Gains from Investment Securities (2017 - 2025)
Historic Gains from Investment Securities for Silo Pharma (SILO) over the last 10 years, with Q2 2025 value amounting to $989.0.
- Silo Pharma's Gains from Investment Securities rose 17855.44% to $989.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $3911.0, marking a year-over-year increase of 23546.93%. This contributed to the annual value of -$104700.0 for FY2022, which is N/A changed from last year.
- As of Q2 2025, Silo Pharma's Gains from Investment Securities stood at $989.0, which was up 17855.44% from $2922.0 recorded in Q1 2025.
- In the past 5 years, Silo Pharma's Gains from Investment Securities ranged from a high of $2922.0 in Q1 2025 and a low of -$129859.0 during Q3 2022
- Moreover, its 4-year median value for Gains from Investment Securities was -$1259.0 (2024), whereas its average is -$18716.3.
- Its Gains from Investment Securities has fluctuated over the past 5 years, first surged by 4222.12% in 2024, then soared by 114871.79% in 2025.
- Silo Pharma's Gains from Investment Securities (Quarter) stood at -$129859.0 in 2022, then soared by 98.57% to -$1862.0 in 2023, then skyrocketed by 32.38% to -$1259.0 in 2024, then surged by 178.55% to $989.0 in 2025.
- Its Gains from Investment Securities stands at $989.0 for Q2 2025, versus $2922.0 for Q1 2025 and -$1259.0 for Q2 2024.